Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study

ABSTRACTThis study is to investigate whether dietary fiber intake prevents vascular and renal damage in a genetic mouse model of systemic lupus erythematosus (SLE), and the contribution of gut microbiota in the protective effects. Female NZBWF1 (SLE) mice were treated with resistant-starch (RS) or i...

Full description

Bibliographic Details
Main Authors: Javier Moleón, Cristina González-Correa, Iñaki Robles-Vera, Sofía Miñano, Néstor de la Visitación, Antonio Manuel Barranco, Natividad Martín-Morales, Francisco O’Valle, Laura Mayo-Martínez, Antonia García, Marta Toral, Rosario Jiménez, Miguel Romero, Juan Duarte
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Gut Microbes
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/19490976.2023.2247053
_version_ 1797320563649150976
author Javier Moleón
Cristina González-Correa
Iñaki Robles-Vera
Sofía Miñano
Néstor de la Visitación
Antonio Manuel Barranco
Natividad Martín-Morales
Francisco O’Valle
Laura Mayo-Martínez
Antonia García
Marta Toral
Rosario Jiménez
Miguel Romero
Juan Duarte
author_facet Javier Moleón
Cristina González-Correa
Iñaki Robles-Vera
Sofía Miñano
Néstor de la Visitación
Antonio Manuel Barranco
Natividad Martín-Morales
Francisco O’Valle
Laura Mayo-Martínez
Antonia García
Marta Toral
Rosario Jiménez
Miguel Romero
Juan Duarte
author_sort Javier Moleón
collection DOAJ
description ABSTRACTThis study is to investigate whether dietary fiber intake prevents vascular and renal damage in a genetic mouse model of systemic lupus erythematosus (SLE), and the contribution of gut microbiota in the protective effects. Female NZBWF1 (SLE) mice were treated with resistant-starch (RS) or inulin-type fructans (ITF). In addition, inoculation of fecal microbiota from these experimental groups to recipient normotensive female C57Bl/6J germ-free (GF) mice was performed. Both fiber treatments, especially RS, prevented the development of hypertension, renal injury, improved the aortic relaxation induced by acetylcholine, and the vascular oxidative stress. RS and ITF treatments increased the proportion of acetate- and butyrate-producing bacteria, respectively, improved colonic inflammation and integrity, endotoxemia, and decreased helper T (Th)17 proportion in mesenteric lymph nodes (MLNs), blood, and aorta in SLE mice. However, disease activity (splenomegaly and anti-ds-DNA) was unaffected by both fibers. T cell priming and Th17 differentiation in MLNs and increased Th17 infiltration was linked to aortic endothelial dysfunction and hypertension after inoculation of fecal microbiota from SLE mice to GF mice, without changes in proteinuria and autoimmunity. All these effects were lower in GF mice after fecal inoculation from fiber-treated SLE mice. In conclusion, these findings support that fiber consumption prevented the development of hypertension by rebalancing of dysfunctional gut-immune system-vascular wall axis in SLE.
first_indexed 2024-03-08T04:41:00Z
format Article
id doaj.art-80f6f931713a4a0eae1385f63b15461c
institution Directory Open Access Journal
issn 1949-0976
1949-0984
language English
last_indexed 2024-03-08T04:41:00Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Gut Microbes
spelling doaj.art-80f6f931713a4a0eae1385f63b15461c2024-02-08T12:02:07ZengTaylor & Francis GroupGut Microbes1949-09761949-09842023-12-0115210.1080/19490976.2023.2247053Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical studyJavier Moleón0Cristina González-Correa1Iñaki Robles-Vera2Sofía Miñano3Néstor de la Visitación4Antonio Manuel Barranco5Natividad Martín-Morales6Francisco O’Valle7Laura Mayo-Martínez8Antonia García9Marta Toral10Rosario Jiménez11Miguel Romero12Juan Duarte13Department of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainCentro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USADepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDepartment of Pathology, School of Medicine, Instituto de Biopatología y Medicina Regenerativa (IBIMER) University of Granada, Granada, SpainDepartment of Pathology, School of Medicine, Instituto de Biopatología y Medicina Regenerativa (IBIMER) University of Granada, Granada, SpainCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo CEU, CEU Universities. Campus Monteprincipe, Boadilla del Monte, San Pablo, SpainCentre for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, Universidad San Pablo CEU, CEU Universities. Campus Monteprincipe, Boadilla del Monte, San Pablo, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainDepartment of Pharmacology, School of Pharmacy and Center for Biomedical Research (CIBM), University of Granada, Granada, SpainABSTRACTThis study is to investigate whether dietary fiber intake prevents vascular and renal damage in a genetic mouse model of systemic lupus erythematosus (SLE), and the contribution of gut microbiota in the protective effects. Female NZBWF1 (SLE) mice were treated with resistant-starch (RS) or inulin-type fructans (ITF). In addition, inoculation of fecal microbiota from these experimental groups to recipient normotensive female C57Bl/6J germ-free (GF) mice was performed. Both fiber treatments, especially RS, prevented the development of hypertension, renal injury, improved the aortic relaxation induced by acetylcholine, and the vascular oxidative stress. RS and ITF treatments increased the proportion of acetate- and butyrate-producing bacteria, respectively, improved colonic inflammation and integrity, endotoxemia, and decreased helper T (Th)17 proportion in mesenteric lymph nodes (MLNs), blood, and aorta in SLE mice. However, disease activity (splenomegaly and anti-ds-DNA) was unaffected by both fibers. T cell priming and Th17 differentiation in MLNs and increased Th17 infiltration was linked to aortic endothelial dysfunction and hypertension after inoculation of fecal microbiota from SLE mice to GF mice, without changes in proteinuria and autoimmunity. All these effects were lower in GF mice after fecal inoculation from fiber-treated SLE mice. In conclusion, these findings support that fiber consumption prevented the development of hypertension by rebalancing of dysfunctional gut-immune system-vascular wall axis in SLE.https://www.tandfonline.com/doi/10.1080/19490976.2023.2247053Hypertensionendothelial dysfunctionfibersgut dysbiosisimmune systemsystemic lupus erythematosus
spellingShingle Javier Moleón
Cristina González-Correa
Iñaki Robles-Vera
Sofía Miñano
Néstor de la Visitación
Antonio Manuel Barranco
Natividad Martín-Morales
Francisco O’Valle
Laura Mayo-Martínez
Antonia García
Marta Toral
Rosario Jiménez
Miguel Romero
Juan Duarte
Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
Gut Microbes
Hypertension
endothelial dysfunction
fibers
gut dysbiosis
immune system
systemic lupus erythematosus
title Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
title_full Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
title_fullStr Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
title_full_unstemmed Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
title_short Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
title_sort targeting the gut microbiota with dietary fibers a novel approach to prevent the development cardiovascular complications linked to systemic lupus erythematosus in a preclinical study
topic Hypertension
endothelial dysfunction
fibers
gut dysbiosis
immune system
systemic lupus erythematosus
url https://www.tandfonline.com/doi/10.1080/19490976.2023.2247053
work_keys_str_mv AT javiermoleon targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT cristinagonzalezcorrea targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT inakiroblesvera targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT sofiaminano targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT nestordelavisitacion targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT antoniomanuelbarranco targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT natividadmartinmorales targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT franciscoovalle targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT lauramayomartinez targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT antoniagarcia targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT martatoral targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT rosariojimenez targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT miguelromero targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy
AT juanduarte targetingthegutmicrobiotawithdietaryfibersanovelapproachtopreventthedevelopmentcardiovascularcomplicationslinkedtosystemiclupuserythematosusinapreclinicalstudy